Abstract: Embodiments of this application relate to a call system, an extension, and a host in the field of communication technologies. An example call system includes a host and an extension. A network side device and the host are connected through a network side link, and the host and the extension are connected through a first terminal side link. The extension exchanges a call data packet with the network side device through the first terminal side link and the network side link. The extension and the host transmit the call data packet through a second terminal side link in response to determining that call quality of the extension is lower than a quality threshold. The first terminal side link is different from the second terminal side link.

Abstract: In one aspect, the present disclosure provides compounds which inhibit bromodomain testis (BRDT). In some embodiments, the compounds inhibit bromodomain-2 of BRDT. In another aspect, the present disclosure provides a method of inhibiting BRDT in a male subject, the method comprising administering to the male subject a therapeutically effective amount of a compound of the disclosure. In some embodiments, the method provides a contraceptive effect in the male subject.

Abstract: Provided are a data processing system and method based on dynamic redundancy heterogeneous encoding, and a device. The method comprises: respectively performing error correction encoding on information to be processed and a processing rule, so as to form encoded information to be processed and an encoded processing rule; processing, by using the encoded processing rule, the encoded information to be processed, so as to obtain response data; and then performing error correction decoding on N pieces of response data, so as to obtain processing result information of the information to be processed.

Abstract: A cell-free fat extract is used for the preparation of a composition or a formulation. The composition or the formulation is effective in (i) preventing and/or treating osteoporosis; (ii) increasing bone volume fraction; (iii) increasing trabecular number; (iv) increasing trabecular connectivity density; (v) increasing bone mineral density; (vi) increasing trabecular thickness; and/or (vii) reducing trabecular separation.

Abstract: A cell-free fat extract may be used for treating osteoporosis. Specifically, the cell-free fat extract can be used to prepare a composition or preparation for preventing and/or treating osteoporosis, in particular osteoporosis due to estrogenic decline. The cell-free fat extract inhibits osteoblast differentiation and osteoclast differentiation, inhibits fusion of the bone marrow macrophage skeleton, improves the structure of hind limb bone, alleviates bone loss and attenuate bone resorption, and improves the mechanical properties of the femur.

Abstract: MiniVectors and compositions containing MiniVectors that target ovarian cancer genes selected from FOXM1, AKT, CENPA, PLK1, CDC20, BIRC5, AURKB, CCNB1, CDKN3, BCAM-AKT2, CDKN2D-WDFY2, SLC25A6, CIP2A, CD133, ALDH1A1, CD44, SALL4, and/or PRDM16, alone or in any combination, are provided, along with uses in the treatment of ovarian cancer.

Abstract: A system includes an infrared camera, an infrared light source, and a processor. The processor is programmed to receive, from the infrared camera, an image of a hand illuminated using the infrared light source, and send the image to a remote server to identify a user corresponding to the hand according to a vein pattern of the hand. An image of a hand illuminated using an infrared light source is received from an infrared camera. Region-of-interest segmentation is performed on the image to generate a segmented image of consistent hand location and orientation. Feature extraction is performed on the segmented image to generate a feature-extracted vein image. Matching of the feature-extracted vein image is performed against a database of feature-extracted vein images to identify a user identity corresponding to the hand.

Abstract: In embodiments of the present invention, there are methods and compositions related to diagnosis and treatment of serous ovarian cancer. In specific embodiments, the invention encompasses methods related to miR-34c in diagnosis and treatment methods for serous ovarian cancer. In specific embodiments, the invention encompasses treatment methods for pancreatic cancer and other responsive cancers.

Abstract: The present invention generally concerns methods and compositions for treating and/or preventing cancer with microRNAs. In specific embodiments, the present invention encompasses a particular microRNA, microRNA-31, as useful in cancer therapy and/or prevention. Specific cancers may be treated, including at least ovarian, prostate, urothelial, osteosarcoma, and glioblastoma.